Search

Aurelio M Bonavia

from San Francisco, CA
Age ~54

Aurelio Bonavia Phones & Addresses

  • San Francisco, CA
  • 2 Tannery Brook Row UNIT 3E, Somerville, MA 02144
  • 615 E Pike St APT 404, Seattle, WA 98122
  • Rockville, MD
  • Baltimore, MD
  • Austin, TX
  • Denver, CO
  • Broomfield, CO
  • Cambridge, MA
  • 2 Tannery Brook Row UNIT 3E, Somerville, MA 02144 (410) 243-7165

Work

Position: Sales Occupations

Education

Degree: Bachelor's degree or higher

Resumes

Resumes

Aurelio Bonavia Photo 1

Senior Director, Clinical Development

View page
Location:
325 Berry St, San Francisco, CA 94158
Industry:
Biotechnology
Work:
Theraclone Sciences - Greater Seattle Area since Mar 2012
Principal Scientist. Head, Biology

Biocision, LLC - Larkspur, CA Apr 2011 - Feb 2012
Senior Director R&D

Novartis May 2008 - Apr 2011
Scientist-Respiratory Viruses Group

Functional Genetics Jan 2006 - Mar 2008
Senior Scientist

NIH-NIAID Aug 2003 - Dec 2005
Research Fellow
Education:
University of Colorado Health Sciences Center 1995 - 2001
PhD, Microbiology and Immunology
Universite du Quebec-Institut Armand-Frappier 1993 - 1995
M.Sc., Virology and Immunology
The University of Texas at Austin 1990 - 1993
B.Sc., Molecular Biology
Medical School-Universidad Nacional Mayor de San Marcos 1988 - 1990
Lima, Peru
Skills:
Immunology
Molecular Biology
Drug Discovery
Assay Development
Drug Development
Virology
Biotechnology
Biochemistry
Cell
Protein Chemistry
Cell Culture
Animal Models
Infectious Diseases
High Throughput Screening
Molecular Cloning
Immunoassays
Clinical Trials
Clinical Development
Elisa
Biomarkers
Biologics
Small Molecules
Clinical Virology
Languages:
French
Spanish
English
Italian
Aurelio Bonavia Photo 2

Aurelio Bonavia

View page
Aurelio Bonavia Photo 3

Aurelio Bonavia

View page

Publications

Us Patents

Tuberculosis Compositions And Methods Of Treating Or Preventing Tuberculosis

View page
US Patent:
20200181209, Jun 11, 2020
Filed:
Aug 15, 2019
Appl. No.:
16/541518
Inventors:
- New York NY, US
Thomas G. Evans - Rockville MD, US
Aurelio M. Bonavia - Rockville MD, US
International Classification:
C07K 14/35
A61K 39/04
A61P 31/06
Abstract:
The present disclosure provides fusion proteins comprising (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.

Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis

View page
US Patent:
20180016599, Jan 18, 2018
Filed:
Jun 21, 2017
Appl. No.:
15/628921
Inventors:
- Rockville MD, US
- Portland OR, US
Aurelio M. Bonavia - Rockville MD, US
Dominick J. Laddy - Rockville MD, US
Louis Picker - Beaverton OR, US
Scott Hansen - Beaverton OR, US
Guangwu Xu - Beaverton OR, US
International Classification:
C12N 15/86
A61K 39/04
C07K 14/35
A61K 39/00
Abstract:
The present disclosure provides cytomegalovirus vectors encoding fusion proteins comprising (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.

Tuberculosis Compositions And Methods Of Treating Or Preventing Tuberculosis

View page
US Patent:
20170362284, Dec 21, 2017
Filed:
Jun 16, 2017
Appl. No.:
15/624853
Inventors:
- Rockville MD, US
Thomas G. Evans - Rockville MD, US
Aurelio M. Bonavia - Rockville MD, US
International Classification:
C07K 14/35
A61K 39/04
Abstract:
The present disclosure provides fusion proteins comprising (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
Aurelio M Bonavia from San Francisco, CA, age ~54 Get Report